Cardiothoracic & vascular anesthesia

High‐sensitive troponinT, interleukin‐8, and interleukin‐6 link with post‐surgery risk in infant heart surgery

Acta Anaesthesiol ScandPublished Secondary analysis of the Mile-1 randomised trial

Authors' conclusion

The peak biomarker concentrations and CPB-time strongly predicted AKI2-3, with IL-6 and IL-8 emerging as strongest predictors.

Study context

Population
Infants undergoing open heart surgery with cardiopulmonary bypass (CPB)
Participants
70 infants
Primary endpoint
Association of peak hs-cTnT, IL-6 and IL-8 with postoperative acute kidney injury (AKI), ventilatory support time and need of vasoactive drugs
Methodological detailsexploratory, double-blinded, Entire study population examined without considering the study drugs
  • Exploratory
  • Double-blinded
  • Entire study population examined without considering the study drugs

Primary result

As reported in the abstract

AKI2-3

OR for AKI2-3, IL-6 > 293 pg/mL

23.4

95% CI 5.3;104.0

OR for AKI2-3, IL-8 > 100 pg/mL

11.5

3.0;44.2

OR for AKI2-3, hs-cTnT >5597 pg/mL

6.1

1.5; 24.5

Further findings

Timing of peak biomarker concentration · 2 h post-CPB

Peak IL-8 at 2 h post-CPB
96%
Peak hs-cTnT at 2 h post-CPB
79%
Peak IL-6 at 2 h post-CPB
63%

Ventilatory support >24 h and vasoactive drugs at 24 h post-CPB

In more than two third of patients with the highest peak IL-8, IL-6 and hs-cTnT; in less than one third of patients with the lowest peak IL-8 and hs-cTnT

Original publication

High‐sensitive troponinT, interleukin‐8, and interleukin‐6 link with post‐surgery risk in infant heart surgery. Acta Anaesthesiol Scand. Published 26 March 2024. doi:10.1111/aas.14405

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.